Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Shares Issued (2022 - 2025)

Historic Shares Issued for Prokidney (PROK) over the last 3 years, with Q3 2025 value amounting to $7.1 million.

  • Prokidney's Shares Issued rose 5888.14% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 10215.02%. This contributed to the annual value of $144.3 million for FY2024, which is N/A changed from last year.
  • Prokidney's Shares Issued amounted to $7.1 million in Q3 2025, which was up 5888.14% from -$3000.0 recorded in Q4 2024.
  • Over the past 5 years, Prokidney's Shares Issued peaked at $7.1 million during Q3 2025, and registered a low of -$542.5 million during Q4 2022.
  • In the last 3 years, Prokidney's Shares Issued had a median value of $2.2 million in 2024 and averaged -$132.7 million.
  • The largest annual percentage gain for Prokidney's Shares Issued in the last 5 years was 5888.14% (2025), contrasted with its biggest fall of 5888.14% (2025).
  • Prokidney's Shares Issued (Quarter) stood at -$542.5 million in 2022, then surged by 100.0% to -$3000.0 in 2024, then skyrocketed by 236833.33% to $7.1 million in 2025.
  • Its Shares Issued stands at $7.1 million for Q3 2025, versus -$3000.0 for Q4 2024 and $4.5 million for Q3 2024.